The Australian Study of HIV and Injecting Drug Use. Part 11: Predicting exposure to hepatitis C and hepatitis B
MetadataShow full item record
Researchers agree that while hepatitis B maybe in control, hepatitis C is present in epidemic proportions among injecting drug users and that current HIV prevention strategies have not been sufficient to halt the spread of this hepatitis virus, although there is some evidence to suggest that incidence rates are stabilizing. Since there is no effective cure and it is unlikely that a vaccine will become available in the foreseeable future all efforts to control the spread of hepatitis C must rely on education and prevention strategies. The Australian Study of HIV and Injecting Drug Use is a cross-sectional national study designed to investigate exposure to and risks for infection with blood-borne viruses. Of those volunteering a usable blood sample for hepatitis C antibody and hepatitis B core antibody testing 55% and 19%, respectively, returned reactive test results. Logistic regression statistical models were used to identify risk factors for hepatitis C and hepatitis B. Risk factors for hepatitis C were identified as duration of use, use of opiates on last injecting occasion, education level, treatment status and having a history of sexually transmissible diseases. Risk factors associated with hepatitis B were duration of use, and use of opiates on last injecting occasion. The lack of identifiable risk factors for hepatitis B suggest that past rather than current injecting and sexual behaviour parterns are required to predict accurately risk of exposure to hepatitis B. In addition to this, one-third of respondents reported being vaccinated against hepatitis B. Respondents perceived themselves to be at greater risk from hepatitis C than from hepatitis B or HIV. A discussion of strategies needed to prevent the spread of the hepatitis viruses will be presented along with recommendations for further research.
Originally published in Drug and Alcohol Review 1997 16(3) pp. 215-220
Copyright Taylor and Francis
A link at the Taylor and Francis web site available at http://www.tandf.co.uk
Showing items related by title, author, creator and subject.
High Rates of Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection in People Who Inject Drugs: A Prospective Cohort StudySacks-Davis, R.; Aitken, C.; Higgs, Peter; Spelman, T.; Pedrana, A.; Bowden, S.; Bharadwaj, M.; Nivarthi, U.; Suppiah, V.; George, J.; Grebely, J.; Drummer, H.; Hellard, M. (2013)Hepatitis C virus reinfection and spontaneous clearance of reinfection were examined in a highly characterised cohort of 188 people who inject drugs over a five-year period. Nine confirmed reinfections and 17 possible ...
Trends in prevalence of HIV infection, hepatitis B and hepatitis C among Australian prisoners - 2004, 2007, 2010Reekie, J.; Levy, M.; Richards, A.; Wake, C.; Siddall, D.; Beasley, H.; Kumar, S.; Butler, Tony (2014)Objective: To report the prevalence of markers for HIV infection, hepatitis B and hepatitis C among Australian prison entrants. Design: Cross-sectional survey conducted over 2-week periods in 2004, 2007 and 2010. Setting: ...
Hepatitis C virus seroprevalence and associated risk factors among male drug injectors in Kermanshah, IranSharhani, A.; Mehrabi, Y.; Noroozi, A.; Nasirian, M.; Higgs, Peter; Hajebi, A.; Hamzeh, B.; Khademi, N.; Noroozi, M.; Shakiba, E.; Etemad, K. (2017)© 2017, Hepatitis Monthly. Background: Infection with hepatitis C virus (HCV) is increasingly recognized as a major global health problem. Objectives: The aim of this study was to measure the prevalence of HCV infection ...